A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...

In late 2021, Amber Salzman interviewed for a job that she had no intention of taking. A relatively new start-up company, called Epicrispr Biotechnologies, was looking for a chief executive, and it ...

A human embryo ‘base edited’ so that it can’t produce a key protein (right), fails to form the mass of cells that gives rise ...